Class information for:
Level 1: THALIDOMIDE//CC 5013//CC 4047

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
5882 1493 35.5 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
605 13295 MULTIPLE MYELOMA//THALIDOMIDE//MYELOMA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 THALIDOMIDE Author keyword 233 34% 38% 562
2 CC 5013 Author keyword 26 87% 1% 13
3 CC 4047 Author keyword 19 80% 1% 12
4 THALIDOMIDE ANALOGUES Author keyword 15 82% 1% 9
5 LENALIDOMIDE Author keyword 14 13% 7% 100
6 POMALIDOMIDE Author keyword 12 37% 2% 27
7 RD GRP PHARMACEUT Address 12 86% 0% 6
8 THALIDOMIDE ENANTIOMERS Author keyword 11 100% 0% 6
9 CEREBLON Author keyword 9 47% 1% 15
10 THALIDOMIDE EMBRYOPATHY Author keyword 7 67% 0% 6

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 THALIDOMIDE 233 34% 38% 562 Search THALIDOMIDE Search THALIDOMIDE
2 CC 5013 26 87% 1% 13 Search CC+5013 Search CC+5013
3 CC 4047 19 80% 1% 12 Search CC+4047 Search CC+4047
4 THALIDOMIDE ANALOGUES 15 82% 1% 9 Search THALIDOMIDE+ANALOGUES Search THALIDOMIDE+ANALOGUES
5 LENALIDOMIDE 14 13% 7% 100 Search LENALIDOMIDE Search LENALIDOMIDE
6 POMALIDOMIDE 12 37% 2% 27 Search POMALIDOMIDE Search POMALIDOMIDE
7 THALIDOMIDE ENANTIOMERS 11 100% 0% 6 Search THALIDOMIDE+ENANTIOMERS Search THALIDOMIDE+ENANTIOMERS
8 CEREBLON 9 47% 1% 15 Search CEREBLON Search CEREBLON
9 THALIDOMIDE EMBRYOPATHY 7 67% 0% 6 Search THALIDOMIDE+EMBRYOPATHY Search THALIDOMIDE+EMBRYOPATHY
10 CPS49 6 80% 0% 4 Search CPS49 Search CPS49

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ORAL APHTHOUS ULCERS 49 94% 1% 17
2 THALIDOMIDE ANALOGS 45 48% 5% 70
3 ANDROGEN ANTAGONISTS 34 93% 1% 13
4 CYCLIC IMIDE SKELETON 29 88% 1% 14
5 PHTHALIMIDE SKELETON 23 86% 1% 12
6 AGENT THALIDOMIDE 17 79% 1% 11
7 HOMOPHTHALIMIDE SKELETON 17 100% 1% 8
8 THALIDOMIDE ANALOG 16 58% 1% 18
9 CC 5013 15 53% 1% 20
10 ENANTIO DEPENDENCE 14 100% 0% 7

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Mechanism of action of lenalidomide in hematological malignancies 2009 120 61 44%
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma 2013 34 46 46%
The thalidomide saga 2007 111 55 47%
Thalidomide 2004 208 133 56%
Thalidomide: Current and potential clinical applications 2000 198 60 75%
Clinical pharmacology of thalidomide 2001 128 58 97%
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma 2010 123 80 30%
Properties of thalidomide and its analogues: Implications for anticancer therapy 2005 86 29 69%
Thalidomide: A review of approved and investigational uses 2003 76 147 67%
Teratogenic effects of thalidomide: molecular mechanisms 2011 39 83 52%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RD GRP PHARMACEUT 12 86% 0.4% 6
2 ANTITUMOR SUBST 3 100% 0.2% 3
3 TRANSLAT DEV CLIN PHARMACOL 2 67% 0.1% 2
4 MOL PHARMACOL SECT 2 13% 1.1% 16
5 HANSENS DIS PROGRAMS 2 19% 0.5% 8
6 TRANSLAT DEV 2 24% 0.4% 6
7 DESENVOLVIMENTO TECNOL FARMACEUT 1 50% 0.1% 2
8 INTENS CARE MED GEN INTERNAL MED 1 100% 0.1% 2
9 JEROME LIPPER MYELOMA HEMATOL ONCOL 1 100% 0.1% 2
10 LHSC UC 1 50% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000137042 MULTIPLE MYELOMA//LENALIDOMIDE//BORTEZOMIB
2 0.0000063804 RECURRENT APHTHOUS STOMATITIS//RECURRENT APHTHOUS ULCERS//RECURRENT APHTHOUS ULCERATIONS
3 0.0000063801 FT IR AND NMR SPECTRA//N PHTHALOYLGLYCINE//INTERMOLECULAR HALOGEN BOND
4 0.0000063145 MYELOMA BONE DISEASE//CAM DR//HEIM
5 0.0000060439 BENZOYLATED DEAE CELLULOSE CHROMATOGRAPHY//POLYADENOSINE DIPHOSPHATE RIBOSE//N NITROSO N ETHYLUREA
6 0.0000052345 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES//DERMATOL LEPROL//M LEPRAE ANTIGEN
7 0.0000045622 FLAVONE ACETIC ACID//DMXAA//5 6 DIMETHYLXANTHENONE 4 ACETIC ACID
8 0.0000037299 ADAPHOSTIN//BONE MARROW MICROVESSEL DENSITY//PEDIAT PEDIAT ONCOL HEMATOL
9 0.0000036557 CUTANEOUS LUPUS ERYTHEMATOSUS//DISCOID LUPUS ERYTHEMATOSUS//SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
10 0.0000031994 UNIFIED EQUATION//DYNAMIC CHROMATOGRAPHY//CHROMWIN